Propanc Biopharma (PPCB) Stock: Biotech Secures $100M Crypto Funding as Shares Tumble

TLDR Propanc Biopharma closed a $100 million funding agreement with Hexstone Capital to build a crypto treasury Company received $1 million upfront with $99 million accessible over 12 months through convertible preferred stock Funds will support digital asset purchases and cancer therapy PRP development ahead of 2026 human trials Stock plunged 10.5% following announcement and [...]

The post Propanc Biopharma (PPCB) Stock: Biotech Secures $100M Crypto Funding as Shares Tumble appeared first on Blockonomi.